Norepinephrine protects cortical neurons against micro glial-induced cell death

被引:63
作者
Madrigal, JLM
Feinstein, DL
Dello Russo, C
机构
[1] Univ Illinois, Dept Anesthesiol, Chicago, IL 60680 USA
[2] Jesse Brown Vet Affairs Res Div, Chicago, IL USA
关键词
nitric oxide; Alzheimer's disease; inflammation; interleukin-1; beta;
D O I
10.1002/jnr.20481
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Interleukin-1 beta (IL-1 beta) is one of the main cytokines involved in the inflammatory response; it has multiple effects that can contribute to cell damage, one of which is the upregulation of the inducible form of nitric oxide (NO) synthase (NOS2) in certain cell types. We demonstrated previously that in vivo, cortical microglial inflammatory responses were increased when noradrenaline (NE) levels were depleted, suggesting that NE can reduce microglial activation. In the present report, we examined the role of IL-1 beta in neurotoxicity induced by microglial-conclitioned media, and possible neuroprotective effects of NE. Incubation of cortical neurons with conditioned media (CM) obtained from lipopolysaccharide (LPS)-treated microglia induced neuronal NOS2 expression and increased neuronal cell death, and these responses were reduced if the neurons were coincubated with interleukin-1 receptor antagonist. Cotreatment of microglial cells with LIPS plus NE potently blocked IL-1 beta production and reduced the ability of the CM to induce neuronal NOS2 and cell death. These results suggest that microglial release of IL-1 beta is an important activator of neuronal inflammatory responses, and that protective effects of NE upon neurons involve a reduction of microglial-derived IL-1 beta. (c) 2005 wiley-Liss, Inc.
引用
收藏
页码:390 / 396
页数:7
相关论文
共 45 条
  • [31] Expression of the inducible nitric oxide synthase in distinct cellular types after traumatic brain injury: an in situ hybridization anal immunocytochemical study
    Petrov, T
    Page, AB
    Owen, CR
    Rafols, JA
    [J]. ACTA NEUROPATHOLOGICA, 2000, 100 (02) : 196 - 204
  • [32] Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential
    Rothwell, N
    [J]. BRAIN BEHAVIOR AND IMMUNITY, 2003, 17 (03) : 152 - 157
  • [33] Interleukin I in the brain: biology, pathology and therapeutic target
    Rothwell, NJ
    Luheshi, GN
    [J]. TRENDS IN NEUROSCIENCES, 2000, 23 (12) : 618 - 625
  • [34] Glial-neuronal interactions in Alzheimer disease: Progressive association of IL-1 alpha(+) microglia and S100 beta(+) astrocytes with neurofibrillary tangle stages
    Sheng, JG
    Mrak, RE
    Griffin, WST
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1997, 56 (03) : 285 - 290
  • [35] Activation of the mitogen-activated protein kinase (ERK1/2) signaling pathway by cyclic AMP potentiates the neuroprotective effect of the neurotransmitter noradrenaline on dopaminergic neurons
    Troadec, JD
    Marien, M
    Mourlevat, S
    Debeir, T
    Ruberg, M
    Colpaert, F
    Michel, PP
    [J]. MOLECULAR PHARMACOLOGY, 2002, 62 (05) : 1043 - 1052
  • [36] Noradrenaline provides long-term protection to dopaminergic neurons by reducing oxidative stress
    Troadec, JD
    Marien, M
    Darios, F
    Hartmann, A
    Ruberg, M
    Colpaert, F
    Michel, PP
    [J]. JOURNAL OF NEUROCHEMISTRY, 2001, 79 (01) : 200 - 210
  • [37] Uttenthal LO, 1998, MICROSC RES TECHNIQ, V43, P75, DOI 10.1002/(SICI)1097-0029(19981001)43:1<75::AID-JEMT11>3.0.CO
  • [38] 2-0
  • [39] Erythropoietin exerts anti-apoptotic effects on rat microglial cells in vitro
    Vairano, M
    Dello Russo, C
    Pozzoli, G
    Battaglia, A
    Scambia, G
    Tringali, G
    Aloe-Spiriti, MA
    Preziosi, P
    Navarra, P
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2002, 16 (04) : 584 - 592
  • [40] Glia and Alzheimer's disease
    Van Eldik, LJ
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2001, 39 (5-6) : 329 - 331